Incidental VTE refers to DVT or PE that are clinically unsuspected at the time of the diagnosis. While incidental PE may be asymptomatic, as many as two-thirds of affected patients report having symptoms consistent with PE, such as fatigue or shortness of breath. However, these nonspecific sym...
Severe congenital protein C deficiency (SCPCD) is rare and there is currently substantial variation in the management of this condition. A joint project by three Scientific and Standardization Committees of the ISTH: Plasma Coagulation Inhibitors, Pediatric/Neonatal Thrombosis and Hemostasis, and Women'...
select article Corrigendum to Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH [J Thromb Haemost. 2022 Jul;20(7):1735-1743] ErratumOpen archive Corrigendum to Diagnosis and management of severe congenital protein C deficiency (SCPCD...
The number of children receiving treatment with anticoagulants for thromboembolic complications has risen over the last decade 1. Children's physiologic response to anticoagulants is inherently different from that of adults 2-6. The complexity of anticoa
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH Author links open overlay panelM. Di Nisio 1 2, A.Y.Y. Lee 3, M. Carrier 4, H.A. Liebman 5, A.A. Khorana 6, for the Subcommittee on Haemostasis and MalignancyShow more...
Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. Khorana, Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH, J. Thromb. Haemost. 13 (5)... MD Nisio,AYY Lee,M ...
Modern computer tomography (CT) with its higher sensitivity and resolution has increased the detection of incidental venous thromboembolism (VTE) in the venous and pulmonary vasculature during routine imaging for cancer staging and response assessment [1]. As a result, up to half of all VTEs diagn...
Di Nisio M, Carrier M, Lyman GH, Khorana AA, for the Subcommittee on Haemostasis and Malignancy. Prevention of venous thromboembolism in hospitalized medical cancer patients: guidance from the SSC of the ISTH. J Thromb Haemost 2014; DOI: 10.1111/jth.12683. Author Information 1 Department of ...
This document gives guidance on deciding the duration of anticoagulation after a first episode of an unprovoked pulmonary embolus (PE) and/or deep vein thrombosis (DVT). Unprovoked PE and DVT are defined as those occurring in the absence of an antecedent (within 3 months) surgical or non‐...
Monitoring patients with the lupus anticoagulant while treated with vitamin K antagonists: communication from the SSC of the ISTH Patients on vitamin K antagonists (VKA) need frequent dose-adjustment based on the prothrombin time (PT) test with results expressed as international normalized ratio (INR...